Page 43 - TD-4-2

Tumor Discovery Understanding glioblastoma invasion and therapy

of survival after surgery for glioblastoma. J Neurosurg. Okada Y. Patterns of intracranial glioblastoma recurrence
2014;121(5):1115-1123. after aggressive surgical resection and adjuvant management:
Retrospective analysis of 43 cases. Neurol Med Chir (Tokyo).
doi: 10.3171/2014.7.Jns132449
2012;52(8):577-586.
39. Ciric I, Ammirati M, Vick N, Mikhael M. Supratentorial
gliomas: Surgical considerations and immediate doi: 10.2176/nmc.52.577
postoperative results. Gross total resection versus partial 48. Rapp M, Baernreuther J, Turowski B, Steiger HJ,
resection. Neurosurgery. 1987;21(1):21-26. Sabel M, Kamp MA. Recurrence pattern analysis of primary
glioblastoma. World Neurosurg. 2017;103:733-740.
doi: 10.1227/00006123-198707000-00005
doi: 10.1016/j.wneu.2017.04.053
40. Simpson JR, Horton J, Scott C, et al. Influence of location
and extent of surgical resection on survival of patients 49. Lombardi G, Pambuku A, Bellu L, et al. Effectiveness of
with glioblastoma multiforme: Results of three consecutive antiangiogenic drugs in glioblastoma patients: A systematic
Radiation Therapy Oncology Group (RTOG) clinical trials. review and meta-analysis of randomized clinical trials. Crit
Int J Radiat Oncol Biol Phys. 1993;26(2):239-244. Rev Oncol Hematol. 2017;111:94-102.
doi: 10.1016/0360-3016(93)90203-8 doi: 10.1016/j.critrevonc.2017.01.018

41. Chambless LB, Kistka HM, Parker SL, Hassam-Malani L, 50. Keunen O, Johansson M, Oudin A, et al. Anti‑VEGF
McGirt MJ, Thompson RC. The relative value of postoperative treatment reduces blood supply and increases tumor
versus preoperative Karnofsky Performance Scale scores as a cell invasion in glioblastoma. Proc Natl Acad Sci U S A.
predictor of survival after surgical resection of glioblastoma 2011;108(9):3749-3754.
multiforme. J Neurooncol. 2015;121(2):359-364.
doi: 10.1073/pnas.1014480108
doi: 10.1007/s11060-014-1640-x
51. Sizoo EM, Braam L, Postma TJ, et al. Symptoms and
42. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, problems in the end-of-life phase of high-grade glioma
Brock C. Temozolomide: A review of its discovery, chemical patients. Neuro Oncol. 2010;12(11):1162-1166.
properties, pre-clinical development and clinical trials.
Cancer Treat Rev. 1997;23(1):35-61. doi: 10.1093/neuonc/nop045
52. Thier K, Calabek B, Tinchon A, Grisold W, Oberndorfer S.
doi: 10.1016/s0305-7372(97)90019-0
The last 10 days of patients with glioblastoma: Assessment of
43. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy clinical signs and symptoms as well as treatment. Am J Hosp
with concomitant and adjuvant temozolomide versus Palliat Care. 2016;33(10):985-988.
radiotherapy alone on survival in glioblastoma in a doi: 10.1177/1049909115609295
randomised phase III study: 5-year analysis of the EORTC-
NCIC trial. Lancet Oncol. 2009;10(5):459-466. 53. Sizoo EM, Koekkoek JA, Postma TJ, et al. Seizures in
patients with high-grade glioma: A serious challenge in the
doi: 10.1016/s1470-2045(09)70025-7
end-of-life phase. BMJ Support Palliat Care. 2014;4(1):77-80.
44. Giladi M, Schneiderman RS, Voloshin T, et al. Mitotic
spindle disruption by alternating electric fields leads to doi: 10.1136/bmjspcare-2013-000456
improper chromosome segregation and mitotic catastrophe 54. Sizoo EM, Pasman HR, Dirven L, et al. The end-of-life phase
in cancer cells. Sci Rep. 2015;5:18046. of high-grade glioma patients: A systematic review. Support
Care Cancer. 2014;22(3):847-857.
doi: 10.1038/srep18046
doi: 10.1007/s00520-013-2088-9
45. Stupp R, Taillibert S, Kanner A, et al. Effect of tumor-
treating fields plus maintenance temozolomide vs 55. Edelstein K, Coate L, Massey C, Jewitt NC,
maintenance temozolomide alone on survival in patients Mason WP, Devins GM. Illness intrusiveness and
with glioblastoma: A randomized clinical trial. JAMA. subjective well-being in patients with glioblastoma.
2017;318(23):2306-2316. J Neurooncol. 2016;126(1):127-135.
doi: 10.1001/jama.2017.18718 doi: 10.1007/s11060-015-1943-6
46. Taphoorn MJB, Dirven L, Kanner AA, et al. Influence of 56. Bergo E, Lombardi G, Guglieri I, Capovilla E,
treatment with tumor-treating fields on health-related Pambuku A, Zagone V. Neurocognitive functions and
quality of life of patients with newly diagnosed glioblastoma: health-related quality of life in glioblastoma patients: A
A secondary analysis of a randomized clinical Trial. JAMA concise review of the literature. Eur J Cancer Care (Engl).
Oncol. 2018;4(4):495-504. 2019;28(1):e12410.
doi: 10.1001/jamaoncol.2017.5082 doi: 10.1111/ecc.12410
47. Konishi Y, Muragaki Y, Iseki H, Mitsuhashi N, 57. Silbergeld DL, Rostomily RC, Alvord EC Jr. The cause of

Volume 4 Issue 2 (2025) 35 doi: 10.36922/td.8578